ReviewHeliyon2023
Targeting CD47 as a therapeutic strategy: A common bridge in the therapy of COVID-19-related cancers.
Milad Zandi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewHeliyon2023
Milad Zandi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.